Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Satoru Yoshihiro
Observed names:
S Yoshihiro,
S. Yoshihiro,
Yoshihiro, Satoru
Institution:
Shimonoseki City Hospital
Observed institutions:
Yamaguchi University,
Shimonoseki City Hospital,
Yamaguchi University Hospital,
Yamaguchi Prefecture Central Hospital,
Saiseikai Yamaguchi General Hospital,
Masuda Red Cross Hospital,
Nagato General Hospital
show all 7
ORCID:
0009-0007-0517-8528
Observed ORCID:
0009-0007-0517-8528
OpenAlex ID:
A5103391866
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder
2003
·
Etsuya Watanabe
, Hideyasu Matsuyama
, et al.
·
Cancer Immunology Immunotherapy
·
91
Centrosome Hyperamplification Predicts Progression and Tumor Recurrence in Bladder Cancer
2004
·
Yoshiaki Yamamoto
, Hideyasu Matsuyama
, et al.
·
Clinical Cancer Research
·
74
A single nucleotide polymorphism in the matrix metalloproteinase‐1 promoter is associated with conventional renal cell carcinoma
2003
·
Hiroshi Hirata
, Katsusuke Naito
, et al.
·
International Journal of Cancer
·
57
PDF
Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer
2002
·
Hideyasu Matsuyama
, Yi Pan
, et al.
·
The Prostate
·
57
Contents Vol. 21, 2001
2001
·
Tetsu Akimoto
, Yasuhiro Ando
, et al.
·
American Journal of Nephrology
·
56
PDF
Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer
2001
·
Kazuo Oba
, Hideyasu Matsuyama
, et al.
·
Cancer Genetics and Cytogenetics
·
49
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma
2020
·
Yoshiaki Yamamoto
, Junji Yatsuda
, et al.
·
International Journal of Clinical Oncology
·
44
Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma
2014
·
The Yamaguchi Uro-Oncology Group
, Shigeru Sakano
, et al.
·
International Journal of Clinical Oncology
·
43
Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.
2001
·
H Matsuyama
, Y Pan
, et al.
·
PubMed
·
43
Risk Group Stratification Based on Preoperative Factors to Predict Survival after Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma
2013
·
The Yamaguchi Uro-Oncology Group
, Shigeru Sakano
, et al.
·
Annals of Surgical Oncology
·
38
Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer
2015
·
The Yamaguchi Uro-Onocology Group
, Takahiko Hara
, et al.
·
International Journal of Clinical Oncology
·
34
Chromosome 16q24 deletion and decreased E-cadherin expression: Possible association with metastatic potential in prostate cancer
1998
·
Yi Pan
, Hideyasu Matsuyama
, et al.
·
The Prostate
·
33
Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer
2004
·
Seiji Yano
, Hideyasu Matsuyama
, et al.
·
Cancer Genetics and Cytogenetics
·
29
Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines
2010
·
Shigeru Sakano
, Hideyasu Matsuyama
, et al.
·
British Journal of Urology
·
26
Allelic loss of 3p25 associated with alterations of 5q22.3∼q23.2 may affect the prognosis of conventional renal cell carcinoma
2005
·
Kazuhiro Nagao
, Shiro Yamaguchi
, et al.
·
Cancer Genetics and Cytogenetics
·
26
Adenocarcinoma Developing in an Ileal Conduit
1995
·
Shigeru Sakano
, Satoru Yoshihiro
, et al.
·
The Journal of Urology
·
25
Numerical aberrations of chromosome 9 in bladder cancer.
2002
·
Manabu Tsukamoto
, Hideyasu Matsuyama
, et al.
·
Cancer Genetics and Cytogenetics
·
22
Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study
2011
·
Tomoyuki Shimabukuro
, Shigeru Sakano
, et al.
·
International Journal of Clinical Oncology
·
17
Clinical significance of lymph node dissection in renal cell carcinoma
2005
·
Hideyasu Matsuyama
, Hiroshi Hirata
, et al.
·
Scandinavian Journal of Urology and Nephrology
·
17
DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries
2004
·
Kenji Matsuda
, Hideyasu Matsuyama
, et al.
·
Cancer Genetics and Cytogenetics
·
16
The Role of Chromosome 8p22 Deletion for Predicting Disease Progression and Pathological Staging in Prostate Cancer
2003
·
H. Matsuyama
, Y. Pan
, et al.
·
Aktuelle Urologie
·
15
Granulocyte Colony-stimulating Factor may Promote Proliferation of Human Bladder Cancer Cells Mediated by Basic Fibroblast Growth Factor
2003
·
Chietaka Ohmi
, Hideyasu Matsuyama
, et al.
·
Scandinavian Journal of Urology and Nephrology
·
12
Renal cell carcinoma: Allelic loss at chromosome 9 using the fluorescent multiplex–polymerase chain reaction technique
2002
·
Koji Fukunaga
, Takashi Wada
, et al.
·
Human Pathology
·
11
Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
2018
·
Yamaguchi Uro-Oncology Group
, Kazuhiro Nagao
, et al.
·
International Journal of Clinical Oncology
·
9
PDF
Clinical significance of allelic loss of chromosome region 5q22.3∼q23.2 in nonpapillary renal cell carcinoma
2002
·
Kazuhiro Nagao
, Satoru Yoshihiro
, et al.
·
Cancer Genetics and Cytogenetics
·
9
Show more works
View as search
Works count:
54
Citation count:
902
H-index:
17
I10-index:
23
Year
Topic
Type
